Terms: = Brain cancer AND CDH1, uvomorulin, 999, P12830, ENSG00000039068, CDHE, Arc-1, UVO, LCAM, CD324, ECAD AND Clinical Outcome
4 results:
1. Components of the canonical and non-canonical Wnt pathways are not mis-expressed in pituitary tumors.
Colli LM; Saggioro F; Serafini LN; Camargo RC; Machado HR; Moreira AC; Antonini SR; de Castro M
PLoS One; 2013; 8(4):e62424. PubMed ID: 23638078
[TBL] [Abstract] [Full Text] [Related]
2. Retrospective protein expression and epigenetic inactivation studies of cdh1 in patients affected by low-grade glioma.
D'Urso PI; D'Urso OF; Storelli C; Catapano G; Gianfreda CD; Montinaro A; Muscella A; Marsigliante S
J Neurooncol; 2011 Aug; 104(1):113-8. PubMed ID: 21127944
[TBL] [Abstract] [Full Text] [Related]
3. [Risk stratification in medulloblastoma: screening for molecular markers].
Ebinger M; Senf L; Scheurlen W
Klin Padiatr; 2006; 218(3):139-42. PubMed ID: 16688669
[TBL] [Abstract] [Full Text] [Related]
4. Methylation of RASSF1A and TRAIL pathway-related genes is frequent in childhood intracranial ependymomas and benign choroid plexus papilloma.
Michalowski MB; de Fraipont F; Michelland S; Entz-Werle N; Grill J; Pasquier B; Favrot MC; Plantaz D
Cancer Genet Cytogenet; 2006 Apr; 166(1):74-81. PubMed ID: 16616114
[TBL] [Abstract] [Full Text] [Related]
